[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610185":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":35,"locations":41,"responsibleParty":57,"collaborators":25,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":25,"eligibilityCriteria":65,"healthyVolunteers":62,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":25,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":25,"overallStatus":78,"whyStopped":25,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Kafrelsheikh University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1","EXPERIMENTAL","TENS Application",[13,14],"Device: Transcutaneous Electrical Nerve Stimulation (TENS)","Dietary Supplement: Lactium",{"label":16,"type":10,"description":17,"interventionNames":18},"Group 2","Lactium",[14],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Transcutaneous Electrical Nerve Stimulation (TENS)","TENS (Frequency 80 \\_100 Hz), (Pulse duration: 150-200 μs, Pain-free stimulation intensity), (Duration;30 min) On one side of the patient's neck, at the location of the stellate ganglion, we positioned two adhesive 25 mm to administer the TENS treatment, while the other side remained untreated. Of the two adhesive electrodes, one was placed near to the paravertebral location in the region of the trapezius muscle on its base near the sixth cervical transverse process, and the other in the region of the stellate ganglion in the supraclavicular aspect (Fig. 2). To obtain a stellate ganglion disrupting, we used a dual-channel TENS stimulator.",[9],null,{"type":27,"name":17,"description":28,"armGroupLabels":29,"otherNames":25},"DIETARY_SUPPLEMENT","Lactium is a natural milk protein hydrolysate that contains a bioactive decapeptide called alpha-casozepine, which has natural relaxing and calming properties. It is used as a dietary supplement ingredient to help manage symptoms of stress, anxiety, and sleep disorders.this supplement will be taken once daily",[9,16],[31],{"name":32,"affiliation":33,"role":34},"fayez f Elshamy, professor","kafrelshekh university","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":25,"email":40},"wafaa sh Elbeltagy, bachelor","CONTACT","00201003802132","wafaashaaban13march@gmail.com",[42],{"facility":43,"status":25,"city":44,"state":45,"zip":25,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Wafaa shaaban hassan elbeltagy","Tanta","Elgharbia","Egypt","EG",{"type":49,"coordinates":50},"Point",[51,52],31.00192,30.78847,{"lat":52,"lon":51},[55],{"name":56,"role":38,"phone":39,"phoneExt":25,"email":40},"Wafaa Shaaban Elbeltagy, Bachelor",{"type":34,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Wafaa Shaaban Hassan Elbeltagy","Senior physical therapist","100610185","the-effect-of-non-invasive-stellate-ganglion-disrupting-on-sleep-disturbances-on-postmenopausal-female-100610185",false,"NCT07224295","The Effect of Non Invasive Stellate Ganglion Disrupting on Sleep Disturbances on Postmenopausal Female","Inclusion Criteria:\n\n1. postmenopausal women who are firstly have sleep disturbances.\n2. Their ages will range from 50- 65 years old.\n3. All patients will be medically stable when attending the study.\n4. BMI≥30.\n\nExclusion Criteria:\n\n\\-\n\nWomen will be excluded from study if:\n\n1. Women with Impaired consciousness.\n2. Inability to communicate with the paramedic because of insufficient language skills.\n3. receiving any medication for sleep disturbances.\n4. Patients who already have sleep disturbances due to another pathological reason or taking any medications which directly affect sleep.\n5. Patients with psychological diseases.\n6. Women who have any cancer diseases.\n7. Diabetic and patient with cardiovascular disease.","FEMALE","50 Years","65 Years",{"count":70,"type":71},32,"ESTIMATED","INTERVENTIONAL",[74],"NA","The goal of this clinical trial is to asses the effect of non invasive stellate ganglion disrupting on sleep distyrbances on postmenopausal female .\n\nThe primary hypothesis:\n\nThere is no effect of noninvasive stellate ganglion disrupting on sleep disturbance parameters of postmenopausal women.\n\nThere is no effect of noninvasive stellate ganglion disrupting on quality of female's life\n\nNon invasive stellate ganglion disrupting with physical modality TENS will be applied on participants of study group. The participants will be screened for estradiol level and assed for the quality of sleep by specialized questionnaire.",[77],"Sleep Disturbances","NOT_YET_RECRUITING","2025-11-22",{"date":81,"type":82},"2025-11-25","ACTUAL",{"date":84,"type":71},"2025-12-01",{"date":86,"type":71},"2026-03-01",{"name":5,"class":6},1]